The comparison of Immune response to Third booster dose with of Vaxzevria or Comirnaty COVID-19 vaccine in healthcare workers after receiving two doses of CoronaVac
Background: The COVID-19 outbreak has significantly impacted public health, with vaccine effectiveness being crucial for control. The efficacy of heterologous prime-boost vaccines remains unclear. This study compared Vaxzevria and Comirnaty as booster doses given 90 days after two CoronaVac doses. M...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-06-01
|
| Серія: | Vaccine: X |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2590136226000306 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|